NPY and Gene Therapy for Epilepsy: How, When,... and Y

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Neuropeptide Y (NPY) is a versatile neuromodulator in the central and peripheral nervous systems.
• NPY influences diverse functions including neuronal excitability, neurogenesis, and metabolic processes.
• NPY acts via multiple receptor subtypes, modulating specific cellular signaling pathways.

Purpose of the Study:

• To review NPY's biological functions, emphasizing its anti-epileptic properties.
• To critically assess NPY's potential as a therapeutic agent for epilepsy.
• To identify key elements for enhancing existing NPY-based gene therapy approaches for epilepsy.

Main Methods:

• Literature review of studies on NPY biology and its role in epilepsy.
• Analysis of NPY receptor subtypes (Y2 and Y5) and their signaling in seizure control.
• Evaluation of NPY overexpression via viral vectors in epilepsy models.

Main Results:

• NPY acts as an endogenous anticonvulsant, particularly through Y2 and Y5 receptors.
• Overexpression of NPY in the brain can suppress seizures in experimental epilepsy models.
• NPY-based gene therapy demonstrates potential for treating epilepsy, including resistant forms.

Conclusions:

• NPY-based gene therapy represents a novel therapeutic strategy for epilepsy.
• Further research is needed to optimize NPY signaling for improved anti-epileptic gene therapies.
• Critical appraisal of NPY's therapeutic applications is essential for clinical translation.